127852-64-6

Basic information

• Product Name: 1,2-Propanediol, 3-(4-methoxyphenyl)-, (2S)-
• CAS NO: 127852-64-6
• Molecular Formula: C10H14O3
• Molecular Weight: 182.219
• Mol File: 127852-64-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1,2-Propanediol, 3-(4-methoxyphenyl)-, (2S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2-Propanediol, 3-(4-methoxyphenyl)-, (2S)-(127852-64-6)
• EPA Substance Registry System: 1,2-Propanediol, 3-(4-methoxyphenyl)-, (2S)-(127852-64-6)

Safety Data

• Hazardous Substances Data: 127852-64-6(Hazardous Substances Data)

Upstream product

• 1214260-85-1 (S)-2-allyloxy-3-(4-methoxyphenyl)-1-propanol 
• 51410-45-8 estragole oxide 
• 127742-93-2 (S)-2-(4-methoxybenzyl)oxirane 
• 140-67-0 Estragole 

Downstream Products

• 791112-31-7 acetic acid 3-[1-(4-methoxybenzyl)-but-2-enyloxy]-1-methylenenonyl ester 
• 791112-30-6 1-methoxy-4-[2-(1-prop-2-ynylheptyloxy)-pent-3-enyl]benzene 
• 791112-29-3 3-(4-methoxyphenyl)-2-(1-prop-2-ynylheptyloxy)-propan-1-ol 
• 220736-25-4 (4R,5S)-5-(hydroxymethyl)-4-(4-methoxyphenyl)-1,3-oxazolidin-2-one 
• 922728-73-2 (4R,5S)-5-(tert-Butyl-dimethyl-silanyloxymethyl)-4-(4-methoxy-phenyl)-oxazolidin-2-one 
• 922728-72-1 carbamic acid 2-(tert-butyl-dimethyl-silanyloxy)-1-(4-methoxy-benzyl)-ethyl ester 
• 856900-01-1 1-(tert-butyl-dimethyl-silanyloxy)-3-(4-methoxy-phenyl)-propan-2-ol 
• 791112-28-2 2-hexyl-4-(4-methoxybenzyl)-[1,3]dioxolane 
• 127742-93-2 (S)-2-(4-methoxybenzyl)oxirane 

Relevant articles and documents

New stereospecific synthesis of Tesaglitazar and Navaglitazar precursors

A new synthetic route of to pharmaceutical intermediates (S)-1a-b and (S)-14 is reported. The reaction pathway is based on the baker's yeast-mediated reduction of the α-alkoxy cinnamaldehydes 9a-c to give the corresponding (S)-alcohols in good yields and

Discovery of (R)-1-[2-hydroxy-3-(4-hydroxy-phenyl)-propyl]-4-(4-methyl-benzyl)-piperidin- 4-ol: A novel NR1/2B subtype selective NMDA receptor antagonist

Starting from Ro-25-6981 as a lead compound, highly potent and selective NR1/2B subtype selective NMDA receptor antagonists, with low activity at α1 adrenergic receptors were developed.